Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02700113 · ClinicalTrials.gov registry record
Investigating Phenotypic Profiles of Children and Adolescents With ASD
A clinical trial, sponsored by Boston University Charles River Campus.
- Completed
- Registry status
- 72
- Enrollment target
NCT02700113: Completed study, sponsored by Boston University Charles River Campus.
NCT02700113 is a clinical trial that has completed, run by Boston University Charles River Campus. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02700113 has completed, sponsored by Boston University Charles River Campus.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
Study Summary
The purpose of this study is to provide a detailed description of language and cognitive profiles found among children and adolescents diagnosed with autism spectrum disorders (ASD). Participants with ASD ages 4-17;12 years who have limited verbal skills will be given comprehensive behavioral assessments to collect data that will advance our understanding of language-related processes in individuals with ASD, the knowledge of which will help in designing future interventions for this population.
Primary Outcome
Interview
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2014-11 |
| Est. Completion | 2019-08-30 |
What the finished NCT02700113 record still lists
NCT02700113 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT02700113 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02700113 about?
NCT02700113 is a clinical study titled "Investigating Phenotypic Profiles of Children and Adolescents With ASD". The purpose of this study is to provide a detailed description of language and cognitive profiles found among children and adolescents diagnosed with autism spectrum disorders (ASD). Participants with ASD ages 4-17;12 years who have limited verbal skills will be given comprehensive behavioral assess...
What is the current status of trial NCT02700113?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2014-11. Estimated completion is 2019-08-30.
What interventions are being tested in trial NCT02700113?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT02700113?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia